盐酸艾司氯胺酮注射液‘三强争霸’，市场潜能引爆行业关注
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">近期</span>，据NMPA官网公示，<strong style="color: blue;">宜昌人福药业</strong>和<strong style="color: blue;">扬子江药业</strong>以仿制3类报产的<strong style="color: blue;"><span style="color: black;">盐酸艾司氯胺酮注射液</span></strong>，前后脚<span style="color: black;">获准</span>上市并视同过评，用于与镇静<span style="color: black;">麻木</span>药联合诱导和实施全身<span style="color: black;">麻木</span>。</p>
<div style="color: black; text-align: left; margin-bottom: 10px;"><img src="https://p3-sign.toutiaoimg.com/tos-cn-i-axegupay5k/b5e907e34d88430894296a89cde66336~noop.image?_iz=58558&from=article.pc_detail&lk3s=953192f4&x-expires=1722437637&x-signature=JFKaVHJRRacZDGxIcmfMvm%2B89FA%3D" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">截图<span style="color: black;">源自</span>：NMPA</p>
</div>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;"><span style="color: black;">盐酸艾司氯胺酮注射液</span></strong>由<strong style="color: blue;">辉瑞</strong><span style="color: black;">开发</span>，<span style="color: black;">拥有</span>镇静兼<span style="color: black;">止疼</span><span style="color: black;">功效</span>，为全国<span style="color: black;">医疗保险</span>乙类品种，限用于与镇静<span style="color: black;">麻木</span>药联合诱导和实施全身<span style="color: black;">麻木</span>。据<strong style="color: blue;"><span style="color: black;">药融云数据库</span></strong><span style="color: black;">表示</span>，盐酸艾司氯胺酮注射液在2023年全国院内市场的<span style="color: black;">营销</span>额逼近3亿元，同比增长达50.5%，市场<span style="color: black;">潜能</span>可期。</p>
<div style="color: black; text-align: left; margin-bottom: 10px;"><img src="https://p3-sign.toutiaoimg.com/tos-cn-i-6w9my0ksvp/04d9a2be15a2408e8a165ef79f01bfda~noop.image?_iz=58558&from=article.pc_detail&lk3s=953192f4&x-expires=1722437637&x-signature=77wTSz8oFFqIzN1sq1vxActTdkA%3D" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">截图<span style="color: black;">源自</span>：药融云全国医院<span style="color: black;">营销</span>数据库</p>
</div>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">日前</span><strong style="color: blue;">辉瑞</strong>的原研品种<strong style="color: blue;"><span style="color: black;">酸艾司氯胺酮注射液</span></strong>未在国内上市，恒瑞医药于2019年拿下盐酸艾司氯胺酮注射液国内首仿，市场<span style="color: black;">始终</span>由恒瑞医药独家占据。随着扬子江和宜昌人福药业的相继<span style="color: black;">获准</span>上市，盐酸艾司氯胺酮注射液的“三王争霸战”已然打响。在这一细分赛道上，恒瑞医药<span style="color: black;">已然</span>打好了头阵，随着扬子江药业和宜昌人福药业的加入，在国内巨头<span style="color: black;">持续</span>加持下，该<span style="color: black;">制品</span><span style="color: black;">将来</span>的市场<span style="color: black;">潜能</span>不容<span style="color: black;">忽略</span>。</p>
<div style="color: black; text-align: left; margin-bottom: 10px;"><img src="https://p3-sign.toutiaoimg.com/tos-cn-i-6w9my0ksvp/695e496bbff84a179af38375d9ca1e41~noop.image?_iz=58558&from=article.pc_detail&lk3s=953192f4&x-expires=1722437637&x-signature=bYBS4jhFtCJCSeC1cQJLTphTjQ8%3D" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">截图<span style="color: black;">源自</span>：药融云中国<span style="color: black;">药物</span>批文数据库</p>
</div>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><span style="color: black;">日前</span>，<strong style="color: blue;">恒瑞医药</strong><span style="color: black;">独霸</span>市场的局面已被<strong style="color: blue;">扬子江药业</strong>和<strong style="color: blue;">宜昌人福药业</strong>打破，<span style="color: black;">麻木</span>剂三大寡头接下来会<span style="color: black;">怎样</span>发力，业界拭目以待。不仅如此，<strong style="color: blue;">国药集团国瑞药业</strong>和<strong style="color: blue;">成都倍特药业</strong>的<span style="color: black;">盐酸艾司氯胺酮注射液</span><span style="color: black;">亦</span>进入了临床<span style="color: black;">实验</span><span style="color: black;">周期</span>。不难预见，该品种<span style="color: black;">将来</span>的市场竞争将愈发白热化。</p>
<div style="color: black; text-align: left; margin-bottom: 10px;"><img src="https://p3-sign.toutiaoimg.com/tos-cn-i-6w9my0ksvp/9c78e0a3b1694a00b1ce35cf6d697add~noop.image?_iz=58558&from=article.pc_detail&lk3s=953192f4&x-expires=1722437637&x-signature=erCr35ySDLH8l18B6YN5epxvdfY%3D" style="width: 50%; margin-bottom: 20px;">
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">截图<span style="color: black;">源自</span>：药融云中国临床<span style="color: black;">实验</span>数据库</p>
</div>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><strong style="color: blue;">人福医药</strong>2023年的营业收入达245.25亿元，为<span style="color: black;">机构</span>上市<span style="color: black;">败兴</span>的新高，净利润达21.34亿元。被誉为“<span style="color: black;">麻木</span>一哥”的人福医药，<span style="color: black;">机构</span>的<span style="color: black;">麻木</span>药<span style="color: black;">制品</span>营收继续保持快速增长，2023年实现<span style="color: black;">营销</span>收入约67亿元，同比增长约16%。</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">2024年<span style="color: black;">迄今</span>，<strong style="color: blue;">人福医药</strong>有14个品种过评，其中<span style="color: black;">注射用盐酸瑞芬太尼</span>、<span style="color: black;">盐酸氢吗啡酮缓释片</span>2个品种为首家过评。<span style="color: black;">另外</span>，<strong style="color: blue;">扬子江</strong>今年<span style="color: black;">败兴</span>有<span style="color: black;">盐酸艾司氯胺酮注射液</span>、<span style="color: black;">替吉奥胶囊</span>、<span style="color: black;">泊沙康唑肠溶片</span>等9个品种过评。</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;">参考<span style="color: black;">源自</span>：</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"> NMPA官网</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"> 药融云数据库</p>
<p style="font-size: 16px; color: black; line-height: 40px; text-align: left; margin-bottom: 15px;"><END></p>
“NB”（牛×的缩写，表示叹为观止）
页:
[1]